Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 627-029-7 | Magnesium, bis[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolato]-, [T-4-(S),(S)]-; (-)-Omeprazole magnesium | 161973-10-0 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Skin Sens. 1 | H317 | H317 |
GHS07 Wng |
State/Form
|
2 | View details | |||||
| Aquatic Chronic 3 | H412 | H412 | |||||||||
| Skin Irrit. 2 | H315 | H315 |
GHS07 Wng |
State/Form
|
2 | View details | |||||
| Skin Sens. 1 | H317 | H317 | |||||||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| STOT SE 3 | H335 (other:upper tra...) (oral) | H335 | |||||||||
| Aquatic Chronic 3 | H412 | H412 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 Wng |
State/Form
|
1 | View details | |||||
| Aquatic Chronic 3 | H412 | H412 | |||||||||
| Acute Tox. 4 | H302 | H302 |
GHS07 Wng |
State/Form
|
1 | View details | |||||
| Eye Irrit. 2 | H319 | H319 | |||||||||
| Not Classified | 1 | ||||||||||
Number of Aggregated Notifications: 5